The Bulgarian Competition Authority fines the National Health Insurance Fund for imposing maximum retail margins for medicines sold under the national health insurance scheme (National Health Insurance Fund)

On 7 July 2010 the Bulgarian Competition Authority (CPC) [1] established that the National Health Insurance Fund (NZOK) [2] has abused its dominant position on the market for medicines reimbursed under the national health insurance scheme by imposing the maximum retail margins to be applied by the individual pharmacies. In Bulgaria certain medicines are reimbursed under the national health insurance scheme administered by the NZOK. Pharmacies sell these medicines to the patients based on the prescription and then reimburse the price of such medicines from NZOK. In order for a pharmacy to be eligible for reimbursements it should

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Alexandr Svetlicinii, The Bulgarian Competition Authority fines the National Health Insurance Fund for imposing maximum retail margins for medicines sold under the national health insurance scheme (National Health Insurance Fund), 1 July 2010, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 32776

Visites 1337

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues